Patents by Inventor Nicola Moore

Nicola Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11994942
    Abstract: A processing device coupled to the memory device can be configured to monitor respective raw bit error rates (RBERs) corresponding to a plurality of groups of memory cells of the memory device. The processing device can also be configured to responsive to determining that an RBER corresponding to a particular group of the plurality of groups of memory cells has met a criteria, adjust a read window budget corresponding to the particular group of memory cells.
    Type: Grant
    Filed: December 21, 2021
    Date of Patent: May 28, 2024
    Assignee: Micron Technology, Inc.
    Inventors: Ezra E. Hartz, Joseph A. De La Cerda, Nicolas Soberanes, Christopher Moore, Bruce J. Ford, Benjamin Rivera
  • Publication number: 20200086139
    Abstract: This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.
    Type: Application
    Filed: April 29, 2019
    Publication date: March 19, 2020
    Applicant: Genentech, Inc.
    Inventors: Asha Das, Ana Maria Abajo Guijarro, Lauren Abrey, Josep Garcia, Magalie Hilton, Yannick Kerloeguen, Nicola Moore
  • Publication number: 20150352204
    Abstract: The present invention provides methods for improving the treatment effect of a chemotherapy regimen of a patient suffering from HER2 positive breast cancer, in particular locally recurrent or metastatic HER2 positive breast cancer, by adding bevacizumab (AvastinĀ®) to a chemotherapy regimen by determining the expression level, in particular the blood plasma expression level, of E-selectin, ICAM-1 or VEGFR-3 relative to control levels of patients diagnosed with HER2 positive breast cancer, in particular locally recurrent or metastatic HER2 positive breast cancer.
    Type: Application
    Filed: December 19, 2014
    Publication date: December 10, 2015
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Ursula Klause, Nicola Moore, Celine Pallaud, Stefan Scherer, Norbert Wild
  • Publication number: 20150148585
    Abstract: This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.
    Type: Application
    Filed: February 6, 2015
    Publication date: May 28, 2015
    Applicant: GENENTECH, INC.
    Inventors: Asha Das, Ana Maria Abajo Guijarro, Lauren Abrey, Josep Garcia, Magalie Hilton, Yannick Kerloeguen, Nicola Moore